[The value of COVID-19 vaccination in the context of Long-COVID]. / Stellenwert der COVID-19-Impfung im Kontext von Long-COVID.
Inn Med (Heidelb)
; 63(8): 840-850, 2022 Aug.
Article
in German
| MEDLINE | ID: covidwho-1971659
ABSTRACT
There are currently no strategies available on how to deal with Long-COVID (COVID "coronavirus disease"). COVID-19 vaccination could be both a preemptive and a therapeutic option for the future. The evaluation of the available studies is complicated by varying definitions. There are, however, indications that (complete) COVID-19 vaccination is able not only to prevent symptomatic infection but also to reduce the risk of Long-COVID. In some patients with Long-COVID, symptoms are modified after (first and/or second) COVID-19 vaccination; however, there is no clear evidence for a real therapeutic effect on Long-COVID.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Experimental Studies
/
Prognostic study
Topics:
Long Covid
/
Vaccines
Limits:
Humans
Language:
German
Journal:
Inn Med (Heidelb)
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS